Medigen Vaccine Biologics Corporation (TPEX:6547)
Taiwan · Delayed Price · Currency is TWD 38.00
+0.40 (1.06%)
Sep 16, 2025, 2:31 PM CST
Medigen Vaccine Biologics Market Cap
Medigen Vaccine Biologics has a market cap or net worth of 12.49 billion as of September 16, 2025. Its market cap has decreased by -21.46% in one year.
Market Cap
12.49B
Enterprise Value
11.09B
Revenue
632.12M
Ranking
n/a
PE Ratio
n/a
Stock Price
38.00
Market Cap Chart
Since August 6, 2015, Medigen Vaccine Biologics's market cap has increased from 2.83B to 12.49B, an increase of 340.65%. That is a compound annual growth rate of 15.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 12.49B | 5.41% |
| Dec 31, 2024 | 11.85B | -48.55% |
| Dec 29, 2023 | 23.04B | 1.10% |
| Dec 30, 2022 | 22.78B | -64.20% |
| Dec 30, 2021 | 63.65B | 192.75% |
| Dec 31, 2020 | 21.74B | 388.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 322.61B |
| PharmaEssentia | 183.07B |
| Bora Pharmaceuticals Co., LTD. | 88.24B |
| Lumosa Therapeutics | 49.78B |
| Lotus Pharmaceutical | 48.91B |
| Oneness Biotech | 33.67B |
| Polaris Group | 29.47B |
| Center Laboratories | 27.25B |